A. Serra

发表

Everolimus Retards Cyst Growth and Preserves Kidney Function in a Rodent Model for Polycystic Kidney Disease

Ming Wu, P. Wahl, M. Le Hir, 2007, Kidney and Blood Pressure Research.

Pulse mTOR inhibitor treatment effectively controls cyst growth but leads to severe parenchymal and glomerular hypertrophy in rat polycystic kidney disease.

Ming Wu, M. Le Hir, R. Wüthrich, 2009, American journal of physiology. Renal physiology.

Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.

Oliver Senn, Dominik Weishaupt, D. Weishaupt, 2010, The New England journal of medicine.

Anti-VEGF antibody treatment accelerates polycystic kidney disease.

R. Wüthrich, A. Serra, Shagun Raina, 2011, American journal of physiology. Renal physiology.

Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions

A. Serra, Talieh Malekshahabi, Niloofar Khoshdel-Rad, 2019, Journal of cellular physiology.

Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.

H. Koepsell, R. Wüthrich, A. Serra, 2013, Kidney international.

Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months.

Oliver Senn, Dominik Weishaupt, D. Weishaupt, 2009, Kidney international.

Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial

K. Pointon, C. Howe, A. Serra, 2011, Clinical Cancer Research.

Hypoxia causes down‐regulation of 11β‐hydroxysteroid dehydrogenase type 2 by induction of Egr‐1

A. Serra, F. Frey, B. Frey, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .

Looking at the (w)hole: magnet resonance imaging in polycystic kidney disease

A. Serra, M. Liebau, Max Christoph Liebau, 2013, Pediatric Nephrology.

Angiotensin II-mediated GFR decline in subtotal nephrectomy is due to acid retention associated with reduced GFR

A. Serra, Xueqi Wang, N. Mohebbi, 2015 .

Prognostic Value and Link to Atrial Fibrillation of Soluble Klotho and FGF23 in Hemodialysis Patients

F. Artunc, A. Serra, C. Mueller, 2014, PloS one.

Exposure to moxifloxacin and cytomegalovirus replication is associated with skin squamous cell carcinoma development in lung transplant recipients

B. Seifert, A. Serra, C. Benden, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Vasopressin-2 receptor antagonists in autosomal dominant polycystic kidney disease: from man to mouse and back.

A. Serra, O. Devuyst, Xueqi Wang, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis

L. French, R. Wüthrich, A. Serra, 2008, The British journal of dermatology.

Combined nephrectomy and pre-emptive renal transplantation in a tuberous sclerosis patient with angiomyolipoma, renal carcinoma and life-threatening abdominal haemorrhages.

H. Moch, R. Wüthrich, A. Serra, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

M. Rudnicki, J. Oliveira, F. Weidemann, 2015, Orphanet Journal of Rare Diseases.

Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease.

V. Tesar, A. Serra, Y. Pei, 2017, Journal of the American Society of Nephrology : JASN.

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.

D. Maahs, H. Mischak, G. Navis, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients.

M. Hersberger, A. Huber, R. Wüthrich, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation

J. Oliveira, C. Wanner, D. Beitner-Johnson, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Impaired expression of key molecules of ammoniagenesis underlies renal acidosis in a rat model of chronic kidney disease.

A. Serra, Xueqi Wang, N. Mohebbi, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate.

R. Wüthrich, A. Serra, D. Poster, 2011, Kidney international.

Impact of mammalian target of rapamycin inhibition on autosomal-dominant polycystic kidney disease.

R. Wüthrich, A. Serra, A. Kistler, 2010, Transplantation proceedings.

Mammalian target of rapamycin and autosomal dominant polycystic kidney disease.

R. Wüthrich, A. Serra, 2009, Transplantation proceedings.

Kidney function and volume progression in unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis or hypoplasia: a case series.

D. Weishaupt, H. Rennert, R. Wüthrich, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study

M. Puhan, A. Serra, J. Braun, 2017, Journal of Nephrology.

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

E. Decullier, Jean Kanitakis, S. Euvrard, 2012, The New England journal of medicine.

Soluble klotho and autosomal dominant polycystic kidney disease.

R. Wüthrich, A. Serra, D. Poster, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Ovarian toxicity from sirolimus.

R. Wüthrich, A. Serra, D. Poster, 2012, The New England journal of medicine.

Low-Dose Oral Sirolimus and the Risk of Menstrual-Cycle Disturbances and Ovarian Cysts: Analysis of the Randomized Controlled SUISSE ADPKD Trial

A. von Eckardstein, R. Wüthrich, A. Serra, 2012, PloS one.

Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation.

J. Haymann, A. Serra, O. Devuyst, 2012, Kidney international.

Mammalian Target of Rapamycin (mTOR)-mediated Effect on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

R. Wüthrich, A. Serra, A. Kistler, 2009 .

Autosomal Dominant Polycystic Kidney Disease: New Treatment Options and How to Test Their Efficacy

R. Wüthrich, A. Serra, A. Kistler, 2009, Kidney and Blood Pressure Research.

Pain Identifies Squamous Cell Carcinoma in Organ Transplant Recipients: The SCOPE‐ITSCC PAIN Study

J. Bouwes Bavinck, C. Proby, E. Olasz, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice

A. Serra, K. Ludin, S. Russmann, 2020, European Journal of Clinical Pharmacology.

Allogeneic islet cells implant on poly-l-lactide matrix to reduce hyperglycaemia in streptozotocin-induced diabetic rat.

M. Hatta, A. Serra, I. Yusuf, 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Disease progress in patients with Morbus Fabry after switching from agalsidase beta to agalsidase alpha

T. Lüscher, A. Serra, C. Schmied, 2014, Internal medicine journal.

25‐Hydroxyvitamin‐D3 serum modulation after use of sunbeds compliant with European Union standards: A randomized open observational controlled trial

R. Braun, A. Serra, B. Weber, 2017, Journal of the American Academy of Dermatology.

Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease.

A. Serra, S. Segerer, Daniela Spichtig, 2014, Kidney international.

Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice.

C. Wanner, W. van Biesen, A. Ortiz, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Sodium retention in rats with liver cirrhosis is associated with increased renal abundance of NaCl cotransporter (NCC).

A. Serra, B. Vogt, F. Frey, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results.

E. Decullier, Jean Kanitakis, S. Euvrard, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostaglandin E2, Tumor Necrosis Factor &agr;, and Pro-opiomelanocortin Genes as Potential Mediators of Cancer Pain in Cutaneous Squamous Cell Carcinoma of Organ Transplant Recipients

J. Bouwes Bavinck, A. Serra, R. Genders, 2017, JAMA dermatology.

Use of Cinacalcet to Control Hyperparathyroidism: Treatment with cinacalcet has been shown to be safe and effective in treating primary, secondary, and tertiary hyperparathyroidism

R. Wüthrich, A. Serra, 2008 .

Maltese cross-like crystals in the urinary sediment of a diabetic patient

R. Wüthrich, A. Serra, G. Fogazzi, 2009, NDT plus.

Reversal of UVA Skin Photosensitivity and DNA Damage in Kidney Transplant Recipients by Replacing Azathioprine

L. French, P. Karran, J. McGregor, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Considerable loss of information on skin cancer occurrence and non‐adherence to clinical practice guideline in renal transplant recipients

L. French, R. Wüthrich, A. Serra, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Swiss clinical practice guidelines for skin cancer in organ transplant recipients.

A. Serra, I. Binet, E. Laffitte, 2010, Swiss medical weekly.

Skin care in solid organ transplant recipients: risk-adjusted follow-up

A. Serra, Anne-Karine Lapointe, C. Mainetti, 2012 .

Pre- and posttransplant management of solid organ transplant recipients: risk-adjusted follow-up.

A. Serra, Anne-Karine Lapointe, C. Mainetti, 2012, Current problems in dermatology.

Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry.

J. Oliveira, C. Wanner, D. Warnock, 2010, Clinical journal of the American Society of Nephrology : CJASN.

A Distinct Urinary Biomarker Pattern Characteristic of Female Fabry Patients That Mirrors Response to Enzyme Replacement Therapy

C. Wanner, H. Mischak, D. Warnock, 2011, PloS one.

Sirolimus Induced Phosphaturia is Not Caused by Inhibition of Renal Apical Sodium Phosphate Cotransporters

S. Amatschek, A. Serra, N. Mohebbi, 2012, PloS one.

[Swiss clinical practice guidelines for skin cancer in organ transplant recipients].

A. Serra, I. Binet, Anne-Karine Lapointe, 2009, Revue medicale suisse.

Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease

C. Pan, R. Beyer, R. Wüthrich, 2014, Journal of internal medicine.

Urinary Biomarkers at Early ADPKD Disease Stage

A. Serra, D. Poster, F. Krauer, 2015, PloS one.

A puzzling case of high serum creatinine in a healthy woman.

A. Serra, F. Frey, D. Nitsch, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).

P. Wahl, M. Le Hir, R. Wüthrich, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease

Andrea Remuzzi, Kanishka Sharma, Michela Bozzetto, 2017, PloS one.

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.

A. Vlahou, H. Husi, J. Staessen, 2015, Journal of the American Society of Nephrology : JASN.

genes regulated during metabolic acidosis Genome-wide gene expression profiling reveals renal

H. Rehrauer, A. Serra, Xueqi Wang, 2015 .

Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria.

A. Serra, B. Vogt, F. Frey, 2002, Journal of the American Society of Nephrology : JASN.

Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study

D. Weishaupt, R. Wüthrich, A. Serra, 2007, BMC nephrology.

Temporal and geographical external validation study and extension of the Mayo Clinic prediction model to predict eGFR in the younger population of Swiss ADPKD patients

M. Puhan, A. Serra, A. Abraham, 2017, BMC Nephrology.

Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients

A. Serra, K. Ludin, S. Russmann, 2021, Journal of clinical medicine.

Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease.

H. Mischak, M. Dakna, R. Wüthrich, 2009, Kidney international.

Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study

K. Bae, H. Mischak, A. Chapman, 2013, PloS one.

The Role of Phospholipase D in Modulating the MTOR Signaling Pathway in Polycystic Kidney Disease

D. Wallace, A. Serra, A. Arcaro, 2013, PloS one.

Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.

R. Wüthrich, A. Serra, D. Poster, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism.

R. Wüthrich, A. Serra, Claudia Wuhrmann, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Building a network of ADPKD reference centres across Europe: the EuroCYST initiative.

A. Köttgen, G. Remuzzi, R. Gansevoort, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Renal Function in Patients Treated with Cinacalcet for Persistent Hyperparathyroidism after Kidney Transplantation

H. Bischoff-Ferrari, R. Wüthrich, A. Serra, 2011, Kidney and Blood Pressure Research.

Pharmacokinetics and Pharmacodynamics of Cinacalcet in Patients with Hyperparathyroidism After Renal Transplantation

M. Hersberger, R. Wüthrich, A. Serra, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Clinical Characteristics and Disease Predictors of a Large Chinese Cohort of Patients with Autosomal Dominant Polycystic Kidney Disease

R. Wüthrich, A. Serra, B. Dai, 2014, PloS one.

Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease.

H. Rehrauer, P. Wahl, M. Le Hir, 2007, Nephrology, Dialysis and Transplantation.

Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism.

R. Wüthrich, A. Serra, H. Marti, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Dual mTOR/PI3K inhibition limits PI3K-dependent pathways activated upon mTOR inhibition in autosomal dominant polycystic kidney disease

H. Mischak, A. Serra, A. Arcaro, 2018, Scientific Reports.

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Sara W. Bird, Erinna F. Lee, Michael D. Kim, 2016 .

Correction: Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study

K. Bae, H. Mischak, A. Chapman, 2013, PLoS ONE.

Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease

P. Wahl, A. Serra, A. Arcaro, 2007, Nephrology.

Quantitative BOLD response of the renal medulla to hyperoxic challenge at 1.5 T and 3.0 T

D. Nanz, A. Boss, A. Serra, 2012, NMR in biomedicine.

Erratum: Building a network of ADPKD reference centres across Europe: the EuroCYST initiative(Nephrology Dialysis Transplantation) (2014) 29 :suppl 4 (iv26-iv32) doi: 10.1093/ndt/gfu091)

A. Köttgen, G. Remuzzi, R. Gansevoort, 2014 .

A Clinical Patient Reporting Tool: Giving ADPKD Patients Back Their Data.

M. Puhan, A. Serra, A. Abraham, 2018, Praxis.

Safety and tolerability of sirolimus treatment in patients with autosomal dominant polycystic kidney disease.

D. Weishaupt, A. Regeniter, R. Wüthrich, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Growth of arachnoid cysts in patients with autosomal dominant polycystic kidney disease: serial imaging and clinical relevance

S. Kollias, R. Wüthrich, A. Serra, 2012, Clinical kidney journal.

Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.

A. Serra, B. Vogt, F. Frey, 2001, The American journal of medicine.

Year : 2010 Sirolimus and kidney growth in autosomal dominant polycystic kidney disease

R. Wüthrich, A. Serra, A. Kistler, 2010 .

Rosuvastatin-induced rhabdomyolysis: case report and call for proactive multifactorial risk assessment and preventive management of statin therapy in high-risk patients

A. Serra, S. Russmann, D. Niedrig, 2023, European Journal of Hospital Pharmacy: Science and Practice.

Soluble klotho and autosomal dominant polycystic kidney disease.

R. Wüthrich, A. Serra, A. Kistler, 2012, Clinical journal of the American Society of Nephrology : CJASN.

P24—Prognostic Indicators of Renal Disease Progression: Natural History Data From the Fabry Registry

J. Oliveira, C. Wanner, D. Warnock, 2012 .

Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry.

J. Oliveira, C. Wanner, D. Warnock, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism.

R. Wüthrich, A. Serra, Claudia Wuhrmann, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.